139 related articles for article (PubMed ID: 8386673)
21. Steroid-dependent ACTH-produced thymic carcinoid: regulation of POMC gene expression by cortisol via methylation of its promoter region.
Mizoguchi Y; Kajiume T; Miyagawa S; Okada S; Nishi Y; Kobayashi M
Horm Res; 2007; 67(5):257-62. PubMed ID: 17220632
[TBL] [Abstract][Full Text] [Related]
22. [ACTH-secreting tumors. Deregulation of the proopiomelanocortin gene and alterations in processing].
Bertagna X; De Keyzer Y; Kahn A; Girard F; Luton JP
Ann Endocrinol (Paris); 1988; 49(4-5):374-6. PubMed ID: 2849366
[TBL] [Abstract][Full Text] [Related]
23. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
[TBL] [Abstract][Full Text] [Related]
24. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
[TBL] [Abstract][Full Text] [Related]
25. The synthesis of ACTH and related peptides by tumours.
White A; Clark AJ; Stewart MF
Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):1-27. PubMed ID: 2167656
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid inhibition of ACTH peptides: small cell lung cancer cell lines are more resistant than pituitary corticotroph adenoma cells.
Farrell WE; Stewart MF; Clark AJ; Crosby SR; Davis JR; White A
J Mol Endocrinol; 1993 Feb; 10(1):25-32. PubMed ID: 8383976
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid repression of pro-opiomelanocortin gene transcription.
Drouin J; Sun YL; Nemer M
J Steroid Biochem; 1989; 34(1-6):63-9. PubMed ID: 2626052
[TBL] [Abstract][Full Text] [Related]
28. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors.
Dahia PL; Honegger J; Reincke M; Jacobs RA; Mirtella A; Fahlbusch R; Besser GM; Chew SL; Grossman AB
J Clin Endocrinol Metab; 1997 Apr; 82(4):1088-93. PubMed ID: 9100578
[TBL] [Abstract][Full Text] [Related]
29. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease.
Nagaya T; Seo H; Kuwayama A; Sakurai T; Tsukamoto N; Nakane T; Sugita K; Matsui N
J Neurosurg; 1990 Feb; 72(2):262-7. PubMed ID: 2153197
[TBL] [Abstract][Full Text] [Related]
30. Cushing Syndrome Due to ACTH-Secreting Pheochromocytoma, Aggravated by Glucocorticoid-Driven Positive-Feedback Loop.
Sakuma I; Higuchi S; Fujimoto M; Takiguchi T; Nakayama A; Tamura A; Kohno T; Komai E; Shiga A; Nagano H; Hashimoto N; Suzuki S; Mayama T; Koide H; Ono K; Sasano H; Tatsuno I; Yokote K; Tanaka T
J Clin Endocrinol Metab; 2016 Mar; 101(3):841-6. PubMed ID: 26700559
[TBL] [Abstract][Full Text] [Related]
31. Variable modes of proopiomelanocortin gene transcription in human tumors.
de Keyzer Y; Bertagna X; Luton JP; Kahn A
Mol Endocrinol; 1989 Jan; 3(1):215-23. PubMed ID: 2536890
[TBL] [Abstract][Full Text] [Related]
32. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
33. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
34. Unrestrained production of proopiomelanocortin (POMC) and its peptide fragments by pituitary corticotroph adenomas in Cushing's disease.
Bertagna X
J Steroid Biochem Mol Biol; 1992 Oct; 43(5):379-84. PubMed ID: 1327071
[TBL] [Abstract][Full Text] [Related]
35. Proopiomelanocortin gene expression in normal and tumoral human lung.
Texier PL; de Keyzer Y; Lacave R; Vieau D; Lenne F; Rojas-Miranda A; Verley JM; Luton JP; Kahn A; Bertagna X
J Clin Endocrinol Metab; 1991 Aug; 73(2):414-20. PubMed ID: 1856267
[TBL] [Abstract][Full Text] [Related]
36. High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors.
Raffin-Sanson ML; Massias JF; Dumont C; Raux-Demay MC; Proeschel MF; Luton JP; Bertagna X
J Clin Endocrinol Metab; 1996 Dec; 81(12):4272-7. PubMed ID: 8954027
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific activity of the pro-opiomelanocortin (POMC) gene and repression by glucocorticoids.
Drouin J; Nemer M; Charron J; Gagner JP; Jeannotte L; Sun YL; Therrien M; Tremblay Y
Genome; 1989; 31(2):510-9. PubMed ID: 2698828
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated targeted expression of toxic genes to adrenocorticotropin-producing pituitary tumors using the proopiomelanocortin promoter.
Lee EJ; Martinson F; Kotlar T; Thimmapaya B; Jameson JL
J Clin Endocrinol Metab; 2001 Jul; 86(7):3400-9. PubMed ID: 11443217
[TBL] [Abstract][Full Text] [Related]
39. Proopiomelanocortin gene promoter elements required for constitutive and glucocorticoid-repressed transcription.
Riegel AT; Lu Y; Remenick J; Wolford RG; Berard DS; Hager GL
Mol Endocrinol; 1991 Dec; 5(12):1973-82. PubMed ID: 1791842
[TBL] [Abstract][Full Text] [Related]
40. Pro-opiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome.
Clark AJ; Lavender PM; Besser GM; Rees LH
J Mol Endocrinol; 1989 Jan; 2(1):3-9. PubMed ID: 2765113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
